PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
03-Oct-2022 ABIVAX ANNOUNCES AD HOC ORDINARY AND EXTRAORDINARY GENERAL MEETING ON NOVEMBER 9, 2022 ABIVAX
03-Oct-2022 Kuros Biosciences Appoints Chris Fair as Chief Operating Officer Kuros Biosciences AG
03-Oct-2022 Acer Therapeutics and Relief Therapeutics Announce Receipt of Notice of Allowance of US Patent Application Covering a Kit Comprising Phenylbutyrate and Sodium Benzoate Relief Therapeutics Holding SA
30-Sep-2022 ABIVAX ANNOUNCES THE RELEASE OF ITS 2022 HALF-YEAR FINANCIAL REPORT ABIVAX
30-Sep-2022 ProBioGen Celebrates "A New Dawn in Biotechnology" B3C newswire
30-Sep-2022 Vitruvia Medical AG: Successful certification of FFP 2 masks with medical approval of LT technologies Vitruvia Medical AG
30-Sep-2022 Vitruvia Medical AG: Half-year results as of 30.6.2022 incl. half-year report Vitruvia Medical AG
30-Sep-2022 Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Reports H1 2022 Financial Results and Highlights Operational Progress (news with additional features) Vivoryon Therapeutics N.V.
30-Sep-2022 Vivoryon Therapeutics N.V.: Vivoryon Therapeutics Announces Successful Private Placement of up to EUR 30 Million (news with additional features) Vivoryon Therapeutics N.V.
30-Sep-2022 Kinarus Therapeutics Announces Discontinuation of the Phase 2 KINETIC Study of KIN001 in Hospitalized COVID-19 Patients Following a Prespecified Interim Analysis of Efficacy and Safety Kinarus Therapeutics Holding AG
29-Sep-2022 IGEA Pharma N.V.: IGEA to get SIX approval to the semi-annual 2022 report disclosure IGEA Pharma N.V.
29-Sep-2022 PM Society Industry Event: Measuring Patient Engagement – Opening a Can of Worms! PM Society
29-Sep-2022 Drägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) of the Regulation (EU) No 596/2014 and Art. 2 (1) of the Delegated Regulation (EU) 2016/1052 of the Commission Drägerwerk AG & Co. KGaA
29-Sep-2022 Top Pharmaceutical and Life Science Events in October (2022) PharmiWeb.Jobs
29-Sep-2022 PHARMANOVIA ENTERS EXCLUSIVE LICENSING COLLABORATION FOR DIAZEPAM BUCCAL FILM Pharmanovia
29-Sep-2022 Almirall and Simcere enter into a licensing agreement for IL-2-mu-Fc Almirall
29-Sep-2022 Molecure reports continued pipeline momentum for 6 months ended 30th June 2022 Molecure S.A.
29-Sep-2022 Dupixent® (dupilumab) approved by FDA as the first and only treatment indicated for prurigo nodularis Sanofi
29-Sep-2022 PacBio Unveils a New Method for Comprehensive, Genome-wide Tandem Repeat Analysis PacBio
29-Sep-2022 Digital innovations, Lifelight and PocDoc, announced as winners of Novartis Biome UK Heart Health Catalyst 2022 Novartis Pharmaceuticals UK